Taxonomy Code 2080P0210X(2080p0210x)
Pediatric Nephrology Physician. Providers: 11
Pediatric Nephrology Physician Providers
| NPI | Name | Type | Address |
|---|---|---|---|
|
MD Alfred J Fish |
Individual |
University Of Minnesota Physicians 516 Delaware St Se Pwb Fourth Floor, Room 4-100 Minneapolis, MN |
|
|
DR. MD Lydia Najera |
Individual |
University Of Minnesota Physicians 516 Delaware St Se, Room 4-100 Minneapolis, MN |
|
|
MD Clifford E Kashtan |
Individual |
516 Delaware St Se Pwb Fourth Floor, Room 4-100 Minneapolis, MN |
|
|
DR. M.D. Blanche Marie Chavers |
Individual |
University Of Minnesota Physicians 516 Delaware Street Se, Pwb Fourth Floor, Room 4-100 Minneapolis, MN |
|
|
M Youngki Kim |
Individual |
516 Delaware St Se Pwb 4th Floor, Room 4-100 Minneapolis, MN |
|
|
DR. MD Sheldon Michael Mauer |
Individual |
University Of Minnesota Physicians 516 Delaware St. Se, Room 4-100 Minneapolis, MN |
|
|
DR. M.D. Michelle Nicole Rheault |
Individual |
2512 S 7th St Pediatric Specialty Care Minneapolis, MN |
|
|
M.D. Avi Katz |
Individual |
2512 S 7th St Minneapolis, MN |
|
|
DR. M.D. Scott Thomas Mcewen |
Individual |
2512 S 7th St Minneapolis, MN |
|
|
M.D. Anne Marie Kouri |
Individual |
2450 Riverside Ave Bldg 6th Minneapolis, MN |
|
|
M.D. Shanthi Balani |
Individual |
2512 S 7th St Minneapolis, MN |
How to obtain, renew, or terminate an NPI
Every health care provider, whether it’s a hospital, pharmacy, or individual specialist, must obtain their own NPI number. This identification number is unique and is assigned upon application. In tod...
| Taxonomy Code | 2080P0210X |
| Specialization | Pediatric Nephrology |
| Display Name | Pediatric Nephrology Physician |
| Taxonomy Group | Allopathic & Osteopathic Physicians |
| Taxonomy Classification | Pediatrics |
| Definition | A pediatrician who deals with the normal and abnormal development and maturation of the kidney and urinary tract, the mechanisms by which the kidney can be damaged, the evaluation and treatment of renal diseases, fluid and electrolyte abnormalities, hypertension and renal replacement therapy. |
| Effective Date | September 30, 2009 |
| Modification Date | September 30, 2009 |